Podofilox Topical Gel shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-01-28 · last update 2026-01-28
Manufacturers: AbbVie Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Condylox , Topical Gel, 0.5% (NDC 0023-6118-03) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/28/2026 Updated 01/28/2026 Discontinued 01/28/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)